TrialPlastic and reconstructive surgery2026

OnabotulinumtoxinA for Platysma Prominence: Safety and Efficacy Results from a Phase 3 Open-Label Repeat Treatment Study.

Deanne Mraz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.